Estradiol-induced vaginal mucus inhibits antigen penetration and CD8(+) T cell priming in response to intravaginal immunization.

David H. Smith Center for Vaccine Biology and Immunology, and the Department of Microbiology and Immunology, University of Rochester Medical Center, NY 14642, United States.
Vaccine (Impact Factor: 3.49). 05/2009; 27(17):2342-9. DOI: 10.1016/j.vaccine.2009.02.025
Source: PubMed

ABSTRACT Although vaginal immunization has been explored as a strategy to induce mucosal immunity in the female reproductive tract, this site displays unique immunological features that probably evolved to inhibit anti-paternal T cell responses after insemination to allow successful pregnancy. We previously demonstrated that estradiol, which induces an estrus-like state, prevented CD8(+) T cell priming during intravaginal immunization of mice. We now show that estradiol prevented antigen loading of vaginal antigen presenting cells (APCs) after intravaginal immunization. Histological examination confirmed that estradiol prevented penetration of peptide antigen into the vaginal wall. Removal of the estradiol-induced mucus barrier by mucinase partially restored antigen loading of vaginal APC and CD8(+) T cell proliferation in vivo. The estradiol-induced mucus barrier may thus prevent exposure to antigens delivered intravaginally, supplementing additional estradiol-dependent mechanism(s) that inhibit CD8(+) T cell priming after insemination or vaginal vaccination.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Female sex hormones are known to regulate the adaptive and innate immune functions of the female reproductive tract. This review aims to update our current knowledge of the effects of the sex hormones estradiol and progesterone in the female reproductive tract on innate immunity, antigen presentation, specific immune responses, antibody secretion, genital tract infections caused by Chlamydia trachomatis, and vaccine-induced immunity.Mucosal Immunology advance online publication, 17 July 2013; doi:10.1038/mi.2013.46.
    Mucosal Immunology 07/2013; · 7.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The availability of water and the ability to access are the key questions arising in developing countries including Algeria. Indeed, due to lack of electricity, the Saharan regions representing 80% of the country are facing major problems to cover drinking water needs. Paradoxically, there is in some of these areas an important quantity of groundwater at shallow depths. On the other hand, Algeria has considerable renewable energy resources, particularly solar and wind energy options that are now relevant solutions to this problem. To date, few facilities specifically photovoltaic were conducted throughout the national territory (Saharan regions and highlands). However vandalism (destruction, robbery, etc.) did not spare these facilities particularly in border areas, such Adrar, and therefore prospective purchasers of such systems are discouraged. A new strategy to deal these actions became necessary for the regions most affected.In this context, we propose to study and compare the two options for solar and wind water pumping applications in the Adrar region. Because it has become necessary that the energy issue arises in new terms. It is proposed now to ask, taking into account the circumstances, which form of energy would be appropriate for what and for which ends. In other words, we will essentially develop a new spirit, a new attitude that would be based on a determination on a case by case basis, of the appropriate energy resource. This will allow to have another vision of the use and the viability of renewable energies.
    Renewable and Sustainable Energy Reviews 12/2011; · 5.51 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Primary T-cell activation at mucosal sites is of utmost importance for the development of vaccination strategies. T-cell priming after vaginal immunization, with ovalbumin and CpG oligodeoxynucleotide adjuvant as model vaccine formulation, was studied in vivo in hormone-synchronized mice and compared to the one induced by the nasal route. Twenty-four hours after both vaginal or nasal immunization, antigen-loaded dendritic cells were detected within the respective draining lymph nodes. Vaginal immunization elicited a strong recruitment of antigen-specific CD4(+) T cells into draining lymph nodes that was more rapid than the one observed following nasal immunization. T-cell clonal expansion was first detected in iliac lymph nodes, draining the genital tract, and proliferated T cells disseminated towards distal lymph nodes and spleen similarly to what observed following nasal immunization. T cells were indeed activated by the antigen encounter and acquired homing molecules essential to disseminate towards distal lymphoid organs as confirmed by the modulation of CD45RB, CD69, CD44 and CD62L marker expression. A multi-type Galton Watson branching process, previously used for in vitro analysis of T-cell proliferation, was applied to model in vivo CFSE proliferation data in draining lymph nodes 57 hours following immunization, in order to calculate the probabilistic decision of a cell to enter in division, rest in quiescence or migrate/die. The modelling analysis indicated that the probability of a cell to proliferate was higher following vaginal than nasal immunization. All together these data show that vaginal immunization, despite the absence of an organized mucosal associated inductive site in the genital tract, is very efficient in priming antigen-specific CD4(+) T cells and inducing their dissemination from draining lymph nodes towards distal lymphoid organs.
    PLoS ONE 12/2013; 8(12):e80545. · 3.53 Impact Factor

Full-text (2 Sources)

Available from
Jun 10, 2014